13F reference period
Q2 2026
Security Snapshot
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) Institutional Ownership
CUSIP: 03209R103
13F Institutional Holders and Ownership History from Q2 2014 to Q3 2026
Institutions Reporting
209
Shares (Excl. Options)
28.32M
Full value: 28,318,139 · shares · 30 Jun 2026Price
$20.18
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- AMPH on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 28,318,139
- Total 13F value
- $571,459,831
- Portfolio coverage rank
- 0%
- Share change
- -3,928,384
- Value change
- -$76,994,315
- Number of holders
- 209
- Underlying class
- Common Stock
- Shares outstanding
- 44,328,981
- SEC-reported price per share
- $25.81
- Insider filing price
- $25.81
Latest holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock is tracked under CUSIP 03209R103.
- 209 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 214 to 209 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$634.05M
Full value: $634,049,603 · USD · 31 Mar 2026.$571.46M
Full value: $571,459,831 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 209 institutions filings for Q2 2026.
Security key
03209R103
13F reference period
Q2 2026
13F holders
209
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
AMPH full holder history
Amphastar Pharmaceuticals, Inc. SEC filings
Amphastar Pharmaceuticals, Inc. company facts
Amphastar Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03209R103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
AMPH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Zhang Jack Y. | 25% | $301,456,363 | 12,524,153 | Jack Y. Zhang | 31 Dec 2024 | |||
| BlackRock, Inc. | 12% | $142,136,789 | 5,333,463 | BlackRock, Inc. | 30 Sep 2025 | |||
| DIMENSIONAL FUND ADVISORS LP | 5.2% | $46,517,059 | 2,305,107 | Dimensional Fund Advisors LP | 30 Jun 2026 |
As of 30 Jun 2026,
209
institutional investors reported holding
shares of
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH).
This represents
64%
of the company’s total
outstanding shares.
28.32M
Full value: 28,318,139 · shares · 30 Jun 202644.33M
Full value: 44,328,981 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 5,224,934 | -3.6% | 0% | $105,439,168 |
| DIMENSIONAL FUND ADVISORS LP | 5.2% | 2,305,107 | +14% | 0.01% | $46,519,189 |
| STATE STREET CORP | 3.7% | 1,642,126 | +2.2% | 0% | $33,138,103 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 1,481,952 | -4% | 0% | $29,905,791 |
| AMERICAN CENTURY COMPANIES INC | 2.7% | 1,176,626 | +16% | 0.01% | $23,744,313 |
| MARSHALL WACE, LLP | 2.4% | 1,066,322 | +4% | 0.02% | $21,518,378 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 969,840 | -0.7% | 0% | $19,575,036 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.1% | 949,238 | -32% | 0.05% | $19,155,615 |
| D. E. Shaw & Co., Inc. | 2% | 887,048 | +33% | 0.01% | $17,900,629 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.8% | 809,568 | +2.8% | 0% | $16,337,082 |
| LSV ASSET MANAGEMENT | 1.4% | 642,014 | -1.5% | 0.02% | $12,956,000 |
| RENAISSANCE TECHNOLOGIES LLC | 1.2% | 525,100 | -5.2% | 0.01% | $10,596,518 |
| GOLDMAN SACHS GROUP INC | 1.1% | 505,360 | +53% | 0% | $10,198,165 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 0.99% | 437,384 | -3.4% | 0.18% | $8,826,439 |
| MORGAN STANLEY | 0.98% | 434,840 | +3.5% | 0% | $8,775,081 |
| UBS Group AG | 0.89% | 393,110 | -6.5% | 0% | $7,932,960 |
| HRT FINANCIAL LP | 0.87% | 387,530 | +590% | 0.01% | $7,820,000 |
| DENALI ADVISORS LLC | 0.85% | 375,965 | +41% | 0.76% | $7,586,974 |
| NORTHERN TRUST CORP | 0.84% | 370,991 | -0.35% | 0% | $7,486,598 |
| Bridge City Capital, LLC | 0.76% | 338,708 | +1.1% | 1.6% | $6,835,127 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.7% | 310,178 | -3.4% | 0% | $6,259,392 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.67% | 298,954 | -9.5% | 0.11% | $6,032,892 |
| ROYCE & ASSOCIATES LP | 0.66% | 294,758 | -27% | 0.05% | $5,948,216 |
| TWO SIGMA INVESTMENTS, LP | 0.56% | 248,115 | +80% | 0% | $5,006,961 |
| FIRST TRUST ADVISORS LP | 0.56% | 246,951 | +64% | 0% | $4,983,471 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Headline period
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 441,467 | $11,400,414 | -$1,267,743 | $25.81 | 43 |
| 2026 Q2 | 28,318,139 | $571,459,831 | -$76,994,315 | $20.18 | 209 |
| 2026 Q1 | 32,346,840 | $634,049,603 | -$32,823,433 | $19.59 | 214 |
| 2025 Q4 | 33,562,174 | $898,754,913 | +$25,045,961 | $26.78 | 234 |
| 2025 Q3 | 32,747,166 | $872,750,705 | +$1,263,197 | $26.65 | 240 |
| 2025 Q2 | 32,731,709 | $751,532,890 | -$21,672,562 | $22.96 | 243 |
| 2025 Q1 | 33,249,489 | $963,158,808 | -$63,190,016 | $28.99 | 240 |
| 2024 Q4 | 35,163,514 | $1,305,816,189 | -$16,188,647 | $37.13 | 261 |
| 2024 Q3 | 35,330,537 | $1,713,563,419 | +$41,888,246 | $48.53 | 276 |
| 2024 Q2 | 34,395,410 | $1,376,025,520 | +$31,905,251 | $40.00 | 268 |
| 2024 Q1 | 33,566,615 | $1,473,434,135 | -$321,352 | $43.91 | 271 |
| 2023 Q4 | 33,295,380 | $2,059,042,180 | +$87,201,045 | $61.85 | 273 |
| 2023 Q3 | 32,003,084 | $1,472,015,140 | +$20,443,300 | $45.99 | 253 |
| 2023 Q2 | 31,353,069 | $1,801,848,806 | +$73,791,648 | $57.47 | 241 |
| 2023 Q1 | 30,206,509 | $1,132,914,126 | +$45,004,448 | $37.50 | 216 |
| 2022 Q4 | 29,163,019 | $817,271,726 | -$23,406,379 | $28.02 | 208 |
| 2022 Q3 | 29,873,966 | $840,021,516 | -$35,843,317 | $28.10 | 196 |
| 2022 Q2 | 30,557,166 | $1,062,910,134 | +$40,970,389 | $34.79 | 217 |
| 2022 Q1 | 29,830,020 | $1,070,980,758 | +$25,890,372 | $35.90 | 201 |
| 2021 Q4 | 29,169,816 | $678,795,680 | +$19,582,653 | $23.29 | 165 |
| 2021 Q3 | 27,926,297 | $530,762,683 | +$12,225,786 | $19.01 | 136 |
| 2021 Q2 | 27,261,956 | $549,556,724 | +$25,712,540 | $20.16 | 142 |
| 2021 Q1 | 26,031,138 | $476,843,577 | +$545,086 | $18.32 | 129 |
| 2020 Q4 | 25,994,308 | $522,683,040 | -$2,775,804 | $20.11 | 126 |
| 2020 Q3 | 26,220,579 | $491,828,114 | -$4,779,592 | $18.75 | 131 |